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Dietary lipid composition has no effect on time to palpable tumor formation
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Animals- 4 week old male TRAMP mice were housed 5 per cage at 22±-0.5°C on a 12 
hour day/night cycle.  They were subjected to the standard AIN-76 diet or diets which 
provided 40% of calories from fish oil or corn oil for 26 weeks at which point they were 
sacrificed for analysis.
PG Analysis-Intracellular cell suspensions were washed withPBS and resuspended
Aliquots of 1 N citric acid, 10% butylated hydroxytoluene (BHT), and PGE2-d4 (100 ng/ml) 
as an internal standard were added to the suspensions.   Prostaglandins were extracted 
with hexane-ethyl acetate (1:1, v/v) three times. Samples were then reconstituted in 
methanol/10 mM ammonium acetate buffer (70:30, v/v), pH 8.5, before analysis by liquid 
chromatography/tandem mass spectrometry (LC/MS/MS). 
The solution was applied to a Sep-Pak C18 cartridge (Waters Corp., Milford, MA) that had 
been preconditioned with methanol and water. Prostaglandins were eluted with methanol. 
The eluate was evaporated under a stream of nitrogen, and the residue was dissolved in 
methanol/10 mM ammonium acetate buffer (70:30, v/v), pH 8.5. 
The extracted prostaglandins were quantitated by the LC/MS/MS method.  LC/MS/MS 
was performed using a Quattro Ultima tandem mass spectrometer (Waters Corp., Milford, 
MA) equipped with an Agilent HP 1100 binary pump HPLC inlet (Agilent Technologies, 
Palo Alto, CA). The prostaglandins were separated using a 2 x 150 mm Luna 3 µ phenyl-
hexyl analytical column (Phenomenex, Torrance, CA). The mobile phase consisted of 10 
mM ammonium acetate, pH 8.5, and methanol. The column temperature was maintained 
at 50°C, and samples were kept at 4°C during the analysis. Individual analytes were 
detected using electrospray negative ionization and multiple reaction monitoring 
monitoring of the transitions m/z 351   271 for PGE2, m/z 349   269 for PGE3, and m/z
355   275 for PGE2-d4. Fragmentation of all compounds was performed using argon as 
the collision gas at a collision cell pressure of 2.10 x 10–3 Torr. 
Fatty Acid Analysis-Dorsal prostate tissues were obtained from 30 week old TRAMP 
transgenic mice.  Tissues were frozen in liquid nitrogen.  Samples were homogenized, and 
subjected to two extractions using a 2:1 Chloroform: ice cold methanol/BHT (50ug/mL) 
solution 0.88% KCl was added to form the aqueous layer.  The samples were then 
centrifuged for 10 minutes at 1000G, 4°C.  Methanolysis reagent (1:4 TMG:methanol, v/v) 
was added to each sample and heated in a water bath.  0.88% KCl was added to each 
sample along with n-hexane.  Two more extractions were performed, removing the upper
aqueous phase.  The n-hexane was evaporated from each sample under a stream of 
nitrogen and in a RT water bath.  The resulting sample was then reconstituted in n-hexane 
and analyzed by gas chromatography. Fatty acid methyl esters were analyzed by gas 
chromatography(HP5890 equipped with FID and 30-m Omegawax capillary column, 
Supelco Chromatography Products). Fatty acids were identified using authentic standards 
(Matreya), quantified by determining areas under identified
peaks (ChemStation Software; Packard Instrument Company, Meriden, CT,
USA).
RNA Extraction and Real-Time PCR (qRT-PCR)-Total RNA from mouse DP (WT, 
TRAMP at 10 and 16 wk of age and PD) was isolated by TRIzol reagent and further 
purified by RNeasy Mini kit as described by Qiagen. Both the quantity and quality of total 
RNA were analyzed by the Agilent Bioanalyzer 2100 system. Total RNA was reverse 
transcribed with an iScript cDNA synthesis kit. qRT-PCR was performed to determine the 
expression of COX-1 and COX-2 using a 1:10 dilution of cDNA with Taqman gene 
expression primers and ABI mastermix according to the manufacturer’s instructions on an 
iCycler IQ qRT-PCR detection system (Bio-Rad). 18s RNA was used as the reference 
gene for all samples. 
Immunoblotting-Total proteins were collected from frozen tissue by standard methods. 
Approximately 40 µg protein was electrophoresed on a 10% SDS-polyacrylamide gel 
followed by standard immunoblotting procedures. Four commercial sources of the primary 
antibodies against COX-2 were analyzed at the following dilutions: 1:500 (Santa Cruz), 
1:750 (Cayman), 1:250 (BD) and 1:500 (Oxford). Two sources of the COX-1 antibodies 
were analyzed at dilutions of 1:500 for the Santa Cruz antibody and 1:1000 for antibody 
for the Cayman Chemical antibody. The secondary antibody was goat anti-rabbit IgG HRP 
for COX-1 (Cayman) and COX-2 (Cayman, BD and Oxford). The donkey anti-goat IgG
HRP was used for COX-1 and COX-2 antibodies from Santa Cruz. Beta-actin was used as 
a loading control. Cell lysates from a wild type mouse vas-deferens was used as positive 
control for COX-1 and COX-2 immunoblotting. 
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ABSTRACT
OBJECTIVES
To determine if diets rich in omega-3 fatty acids 
derived from fish oil modify prostate 
carcinogenesis in the TRAMP model
To investigate the effects of diets rich in omega-3 
fatty acids derived from fish oil on prostate 
prostaglandin production in control and TRAMP 
mice.
To examine the expression of COX-I and COX-II 
during prostate carcinogenesis in TRAMP mice.
The “Western” dietary pattern found in affluent nations 
and characterized as high in lipid content, low in fiber, rich in red 
meat, and limited in fruits and vegetables is correlated with a 
greater risk of prostate cancer.   In addition, it is hypothesized that 
diets rich in omega-3 fatty acids, such as found in many fish, may 
be preventive against prostate cancer.  The most abundant and 
most thoroughly studied fatty acids found in fish oil are 
eicospentanoic acid (EPA) and docosahexanoic acid (DHA).  
Supplementation with these fatty acids has been shown to inhibit
growth of prostate cancer cells in culture.  It is hypothesized that 
these fatty acids exert chemopreventive effects through a 
suppression of PGE2 and enhancement of PGE3 synthesis, 
subsequently reducing proinflammatory signals and/or enhancing 
antiproliferative/proapoptotic signaling.  
We have chosen to investigate the effects of a high fish oil 
diet on prostate cancer chemoprevention in vivo with the TRAMP 
model of murine prostate cancer.  This transgenic mouse 
develops invasive adenocarcinoma of the prostate as a result of 
androgen-driven, prostate-specific expression of the SV-40 T/t 
antigen.  Male mice (4 week old) were placed on semipurified 
diets containing 40% of calories from fish oil (HFO) or corn oil
(HCO) for 26 weeks.  Time to 2cm diameter palpable tumor was 
recorded.  Upon sacrifice, tissues were collected and 
concentrations of tissue fatty acids and prostaglandins were 
obtained.  Prostate tumorigenesis was not altered by a lipid 
source.  However, prostatic lipid profiles mimicked dietary 
changes.  In addition, prostate PGE2 was reduced by the HFO 
diet in wild-type mice, but no changes in the prostates of TRAMP 
mice.  PGE3 was increased by HFO diet in both wild-type and 
transgenic mice.  
The resistance of TRAMP mice to anticancer activity by 
omega-3 rich diets was further investigated.  We observed that 
COX expression was significantly lost during progression of 
TRAMP carcinogenesis based upon western blots, mRNA 
expression, and immunohistochemistry.  These studies suggest 
that the TRAMP model, with carcinogenesis induced by prostatic 
expression of SV40 T antigens disrupts fatty acid and lipid 
metabolism in a manor that produces resistance to dietary 
intervention.  
In conclusion, the HFO diet did not prevent prostatic 
tumorigenesis in the TRAMP model but did affect levels of PGE2 
and PGE3 and substrates for their metabolism.
Dietary lipid and genotype interactions on the 
prostate content of prostaglandin E2
Dietary lipid and genotype interactions on the prostate content of 
prostaglandin E3
COX-1 and COX-2 gene expression is lost during 
TRAMP carcinogenesis – RT-PCR analysis
Epidemiologic and cell culture studies have suggested 
that the types of dietary lipids are associated with the risk of
prostate cancer. In brief, diets rich in saturated fats and omega-
6 fatty acids are hypothesized to increase risk while diets 
containing omega-3 fatty acids are proposed to reduce risk.   
Arachidnonic acid, a predominate dietary omega-6 fatty 
acid, is metabolized through the cyclooxygenase (COX) enzyme 
pathways to prostaglandin E2 (PGE2). PGE2 levels have been 
found to be elevated in prostate cancer and is associated with 
aggressive tumor behavior and biomarkers of enhanced  
angiogenesis and invasiveness (2).
Diets rich in fish products contain much greater 
concentrations of omega-3 fatty acids.  The most abundant and 
thoroughly studied of these fatty acids are eicospentanoic acid 
(EPA) and docosahexanoic acid (DHA).  These fatty acids can 
inhibit the growth of culture prostate cancer cells.  EPA and 
DHA have been shown to antagonize the effects of omega-6 
fatty acids through COX-2, thereby decreasing levels of PGE2 
(3).  Moreover, increased omega-3 fatty acids can lead to 
increased production of the anti-inflammatory PGE3 (4).
We have chosen to investigate the effects of a a fish oil 
diet on prostate carcinogenesis in the TRAMP mouse model.  
TRAMP mice express an androgen driven SV-40 T/t transgene
causing silencing of the p53 and Rb genes, which are common 
mutations seen in advanced prostate cancer. We also report the 
effects of consuming a fish oil diet on prostate fatty acid content, 
prostaglandin production, and the expression of COX enzymes 
during TRAMP carcinogesis.
COX-1 and COX-2 gene expression is lost during 
TRAMP carcinogenesis – Western analysis
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Diet alters prostatic fatty acid pattern
 A diet rich in  fish oil diet does not 
inhibit  prostate carcinogenesis in 
the TRAMP model
 Prostate fatty acids are changed 
in response to patterns of fatty 
acids found in the diet
 Prostaglandin synthesis is 
affected by dietary fatty acid 
content in wild-type mice but not in 
the TRAMP model
 TRAMP carcinogenesis is 
assocaited with a loss of  COX 
expression.  
The loss of COX expression in 
TRAMP results in a resistance to 
the chemopreventive effects of a an 
an omega-3 fatty acid rich diet. This 
works suggests that disruptions in 
p53 and RB pathways alters the 
cellular response to fatty acids and 
PGs.
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Figure 1 - The percentage of TRAMP mice free of a palpable prostate tumor  (2 cm 
diameter) over time.  Mice were examined weekly to asses the presence or 
absence of a palpable tumor.  
Figure 2 - Prostaglandin E2 production in the prostates of wild-type mice 
is reduced by diets rich in fish oil, but has no effect in TRAMP mice.  
Prostaglandin levels were determined using MS.  N=6-7 per diet
This work is dedicated to the memory of Dr. 
Russell D. Klein, our colleague, mentor, and 
friend, who recently passed away after a year-
long battle with leukemia.  
Special thanks to Kristin Keatley and Rob 
Rengel for technical assistance and 
commentary.
Figure 3 - The HFO diet increased levels of prostaglandin E3 in wild-type mice, 
which TRAMP mice show a significantly lower content, regardless of diet.  
Prostaglandin concentrations were determined using MS. N=6-7 per diet.
Figure 4 - Prostatic fatty acid pattern mimics dietary intake.  Relative fatty 
acid patterns were determined using the Folch method of lipid extraction and 
gas chromatography.  N=3 per diet. HFO diet decreases the % of arachidonic
acid and increases the % DHA and EPA.  
Figure 5-Western blot analysis of COX-1 and COX-2 protein levels in DP 
tissue from WT (10 wk), TRAMP DP (10 and 16 wk), and from histological 
confirmed poorly-differentiated tumor tissue (PD). Mouse vas deferens 
tissue was used as positive control for COX (+). Tissue lysates from two different 
mice were analyzed for each tissue type and images are representative of two 
independent experiments.
Figure 6-Quantitative RT-PCR of COX-1 and COX-2 mRNA levels in WT (10 
wk) and TRAMP DP tissues (10 and 16 wk), and PD tumor. Each bar 
represents the mean COX-1 or COX-2 mRNA expression (error bars are 95% 
confidence intervals) of five animals relative to a common calibrator sample 
generated by pooling the dorsal, ventral, and lateral prostates of a single wild-
type mouse. 18s RNA levels were used to normalize the expression of individual 
samples. Data points with an asterisk are significantly different from other data 
points in the same panel (p < 0.05). 
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